India Achieves 38% Reduction in TB Deaths by 2025
India's TB mortality rate has decreased significantly, but challenges remain in achieving universal testing and treatment.
India has reduced TB deaths by 38% from 2015 to 2025, reaching approximately 263,000 deaths.
Despite progress, India still accounts for a significant share of global TB deaths, necessitating improved diagnostic and treatment access.
Political will and increased domestic funding are crucial for sustaining progress and achieving WHO targets.
India has made significant strides in combating tuberculosis (TB), achieving a 38% reduction in TB-related deaths between 2015 and 2025, according to the WHO Global Tuberculosis Report 2026. This milestone positions India alongside China as one of the few high-burden countries to meet this goal. However, the report highlights that India's TB mortality rate remains unacceptably high, with the nation accounting for a quarter of global TB deaths, emphasizing the need for continued efforts in diagnosis and treatment.
The WHO report indicates that while India has successfully reduced TB deaths, the country must maintain this downward trend. To do so, it is essential to identify severely ill patients early and provide timely nutritional support. The Central TB Division's guidance for 2025 encourages states to adopt differentiated care approaches and conduct standardized reviews of TB deaths to improve response strategies.
Access to rapid molecular testing for TB is on the rise, with 46% of cases tested using WHO-recommended rapid diagnostic tests in 2025, up from 38% in 2024. Despite this progress, the target of 100% coverage by 2027 remains unachieved. Dr. Urvashi Singh from AIIMS Delhi notes that various policy initiatives, including cash transfers under the Nikshay Poshan Yojana, have contributed to this reduction in deaths, but emphasizes that prevention must be the next focus.
Globally, TB continues to pose a significant public health challenge, with an estimated 10.7 million new cases and 1.23 million deaths in 2024. The WHO identifies TB as a leading cause of death from a single infectious agent, with high-burden countries accounting for 87% of cases. To meet the End TB Strategy's targets, which aim for a 90% reduction in deaths by 2030, substantial improvements in diagnostic and treatment coverage are necessary, along with increased funding.
Looking ahead, the need for political commitment and domestic funding in high-burden countries is more critical than ever, especially in light of anticipated cuts to international donor funding. Achieving the ambitious targets set by the WHO and UN member states will require intensified efforts to improve TB diagnostics, treatment access, and preventive measures to combat this persistent global health issue.




